Transrectal vs transperineal biopsy: Comparable outcomes and QoL
"It appears that the TR and TP biopsy procedures are essentially comparable in various aspects of the procedure," writes Badar M. Mian, MD.
How the 2022 CMS final rule will affect urologists
Urology as a specialty will see a 3.71% decrease in overall payments.
Financial tasks you should complete by the end of the year
Be sure to replenish your emergency fund if necessary.
What are your thoughts on proposals that physicians should communicate with their patients by text?
"Without any real data [showing] that this improves anything, it just makes us too accessible," says one urologist.
Practical ways to address burnout in your urology practice
Keeping up to date on EHR updates is 1 step you can take.
Radiation therapy as monotherapy effective in oligometastatic renal cell carcinoma
“These findings are exciting because we’re challenging the dogma in radiation oncology that RCC is biologically radioresistant," ,” said lead author Chad Tang, MD.
Higher testosterone dosing may be required for patients with a higher BMI
In a recent study Martin M. Miner, MD, and co-authors investigated the effect of BMI on the pharmacokinetic profile or dosing of testosterone therapies in men with TD.
PSMA/PET-derived risk stratification tool performs strongly in prostate cancer study
The nomogram was significantly prognostic of key clinical end points and achieved outcomes comparable to STAR-CAP and superior to other established risk-stratification tools.
Transitional Zone sampling can be spared in some men with suspicious prostate cancer lesions on mpMRI
“This zone-dependent biopsy strategy warrants prospective evaluation to optimize the extent of systematic biopsies in presence of suspicious mpMRI lesions,” the authors wrote.
IL-15 superagonist N-803 shows strong clinical activity in papillary NMIBC
Data from the phase 2/3 QUILT-3.032 trial showed that adding N-803 to BCG met the primary end point of disease-free survival in patients with BCG-unresponsive, high-grade non–muscle-invasive bladder cancer and papillary disease.
Investigators examine effect of statins on LUTS secondary to BPH
In a recent Journal of Urology study, Jordan J. Kramer, MD, and co-authors examined whether statins impact LUTS incidence in asymptomatic men and progression in symptomatic men with BPH.
Biomarker emerges for Botox response in patients with OAB
A decrease in urinary ATP levels following onabotulinumtoxinA (Botox) injections corresponded to clinical improvements in overactive bladder symptoms.
Olaparib plus bipolar androgen therapy shows promise in prostate cancer
"Clinical benefit was observed regardless of homologous recombination repair gene mutational status," the study authors wrote.
Novel vaccine MV140 effective at treating recurrent UTIs
The MV140 vaccine "will be a game changer for women's health in the future," says J. Curtis Nickel, MD.
2 Clarke Drive Cranbury, NJ 08512